.png){kind=icon}
返回
Guidelines impact cholesterol management
.png){kind=icon}
PRE
AI
DOI：10.1016/j.jacl.2019.03.002.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
BACKGROUND: Previous research demonstrates increased utilization of high-intensity statins, but unchanged low-density lipoprotein cholesterol (LDL-C) levels, immediately after the 2013 American College of Cardiology (ACC) and the American Heart Association (AHA) guideline release. OBJECTIVE: The objective of this study was to determine achievement of statin therapy goals in patients with atherosclerotic cardiovascular disease (ASCVD) before and up to 4 years after the 2013 ACC/AHA guideline release compared with LDL-C goals of <70 mg/dL and <100 mg/dL previously recommended by other professional societies. METHODS: The single-system cohort study used medical records, laboratory results, and claims data (November 2012-October 2017) of adults with claim for a statin, ASCVD diagnosis in propensity score-matched analyses. RESULTS: Among 1938 patients (mean age 70 11, 48% female) with ASCVD, the percentage on high-intensity statin therapy significantly increased over time: 24% in 2013, 34% 2014, 42% 2015, and 49% 2016 (P<.0001). The increase in high-intensity statin use was 13 to 22% higher among patients managed by subspecialists (cardiologist and endocrinologists) compared with those managed by primary care providers. Mean LDL-C level was slightly, but not significantly, lower in 2013 (80 mg/dL) than in other years: 85 mg/dL in 2014, 83 mg/dL in 2015, and 82 mg/dL in 2016. The proportion of patients reaching LDL-C goals ranged from 51% to 56% for the <70 mg/dL target and 77% to 85% for the <100 mg/dL target over time. CONCLUSION: High-intensity statin use among secondary prevention patients increased significantly immediately after the 2013 ACC/AHA guidelines release, primarily in those managed by sub specialists. However, the mean LDL-C and the proportion of patients reaching LDL-C <70 mg/dL and < 100 mg/dL remain unchanged across comparison cohorts. (C) 2019 National Lipid Association. All rights reserved.
Keyword:
Statin
Cholesterol
LDL-C
2013 ACC/AHAl
ASCVD
2018 ACC/AHA
Non-HDL
Hyperlipidemia
Dyslipidemia
High-intensity
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.6
论文数:
2.6K
被引数:
4.3K
机构
引用论文
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE美国临床内分泌医师协会和美国内分泌学会血脂异常管理和心血管疾病预防指南.png)
ENDOCRINE PRACTICE
ENDOCRINE PRACTICEIF4.6
PREAI
分享收藏Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices NationwideJAMA CARDIOLOGY
OAAI
JAMA CARDIOLOGYIF14.1
OAAI分享收藏
查看更多内容